通过佩戴框架眼镜、隐形眼镜或进行近视屈光矫正手术，可以让近视者重新看清远处物体。这些方法属于光学矫正，能有效改善视力，但本质 上是"代偿"而非"治愈"。"让眼睛完全恢复到未近视的状态目前无法实现。"付晶说，多数近视是由于眼轴过度增长导致的，而眼轴一旦变长就 无法缩短。因此，近视可以通过外部手段矫正视力，但无法从根本上"治愈"眼球结构的改变。 新华社北京6月6日电（记者侠克）现代社会快节奏的生活模式下，电子设备使用时长激增，不良用眼习惯普遍，近视、眼疲劳等问题威胁各年 龄段人群的眼部健康。每年的6月6日是全国爱眼日，针对公众关注较高的几类问题，记者采访了首都医科大学附属北京同仁医院斜视与小儿眼 科主任医师付晶。 ——如何区分真性近视和假性近视？近视能否被治愈？专家表示，区分真性近视和假性近视的金标准是散瞳验光，需要在医院或专业视光机 构，使用睫状肌麻痹剂进行散瞳，放松眼部调节肌肉后再进行验光。如果散瞳后仍存在近视度数，说明是真性近视，如果度数消失或明显降 低，视物恢复清晰，则为假性近视。 ——关灯后看手机对眼睛伤害有多大？付晶说，黑暗环境中瞳孔扩大，让更多光线进入眼球，而手机屏幕产生的短波有害蓝光可穿透晶状体， ...

Core Viewpoint - The article emphasizes the increasing prevalence of myopia among children and adolescents in China, highlighting the need for awareness and preventive measures to combat this public health issue [2][3][4]. Group 1: Myopia Statistics and Trends - As of 2022, the overall myopia rate among children and adolescents in China is 51.9%, with specific rates of 36.7% in elementary school, 71.4% in middle school, and 81.2% in high school [2]. - The myopia rate for first-grade students is approximately 10%, which escalates to nearly 60% by sixth grade, indicating an average increase of about 9 percentage points per grade [2]. Group 2: Contributing Factors - Environmental factors, such as academic pressure and increased screen time, are significant contributors to the rise in myopia among children [3]. - Insufficient outdoor activity is also a critical factor, as lack of exposure to natural light can increase the risk of developing myopia [3]. Group 3: Preventive Measures - Experts recommend developing good eye habits, engaging in outdoor activities, and maintaining a healthy diet to mitigate myopia risks [3]. - The "20-20-20" rule is suggested as an effective method for eye relaxation, which involves looking at an object 20 feet away for 20 seconds after every 20 minutes of close-up work [3]. Group 4: Vision Check Recommendations - Regular vision checks are advised, with specific frequencies based on the child's risk level: once a year for low-risk children, every six months for those with mild myopia, and every 3-4 months for those with moderate to high myopia [4]. - Establishing a refractive development record for children is recommended to monitor vision changes and enable early intervention [4]. Group 5: Collaborative Efforts - The Henan Provincial Eye Hospital is collaborating with local education departments to create refractive health records for students and provide on-site guidance on eye health [4]. - A big data platform for myopia prevention is being developed to identify high-risk students early and promote healthy behaviors [4]. Group 6: Treatment Options - The article discusses the use of OK lenses (orthokeratology lenses) for myopia control, which reshape the cornea overnight to improve daytime vision [6]. - Caution is advised for certain children regarding the use of OK lenses, particularly those with active eye conditions or poor hygiene practices [6][7].

Core Points - The 30th National "Eye Care Day" was celebrated with the theme "Focus on Universal Eye Health" to promote the importance of outdoor activities for eye health [1] - The Sun Yat-sen University Eye Center launched the first urban "Eye Care Map" in the country, a digital tool aimed at protecting residents' eye health by quantifying the impact of urban street environments on eye health [2] - The Eye Care Map allows citizens and tourists to find the most "eye-friendly" routes for commuting and leisure, integrating various disciplines such as ophthalmology, public health, remote sensing, artificial intelligence, and urban planning [2] - The map generates a real-time eye protection index for each street in Guangzhou, providing optimal routes based on parameters like green visibility and air quality [2] - The event also saw the introduction of the second-generation AI ophthalmology mobile clinic, which can screen eye diseases and provide treatments, enhancing the city's healthcare capabilities [3]

当前，随着电子产品的广泛普及和生活节奏的日益加快，眼部健康问题逐渐成为社会各界关注的焦点。 根据WHO《2024世界卫生统计报告》，全球约有22亿人面临视力问题。在我国，患者对于眼科疾病的 治疗需求正持续上涨，且覆盖了全年龄段。 首都医科大学附属北京朝阳医院眼科主任医师陶勇概括了当前眼健康的三大挑战：青少年近视呈现低龄 化、干眼病呈现全民流行化、视疲劳与慢性炎症叠加问题普遍化。他特别强调，眼健康是身心健康不可 或缺的重要组成部分。 京东健康互联网医疗业务部相关负责人表示，当前平台关于眼相关的问诊及健康咨询日均高达1万多 次。分析显示，大众对眼疾主要存在三大误区：一是家长过度聚焦孩子近视问题，忽视斜视、弱视等其 他眼病；二是上班族常将视疲劳视为常态，疏于定期专业检查；三是中老年人误将老花眼视作自然衰老 现象，延误白内障等可治疗眼病的及时就医。 面对眼部健康挑战，陶勇指出，科学保养策略至关重要，具体应涵盖环境与习惯的双重优化、营养与运 动的协同作用、数字化护眼工具的合理应用，以及必要的药物干预。 中新网北京6月6日电(赵方园)"眼健康不仅要视力好，还要看得见、看得清楚，看得舒服。"6月6日，北 京大学第一医院眼科 ...

Core Viewpoint - The article emphasizes the growing public health issue of myopia in China, particularly among children and adolescents, and highlights the importance of early prevention and intervention strategies for eye health [1][3]. Group 1: Myopia Prevention and Control - Myopia is primarily caused by genetic and environmental factors, with lifestyle changes being crucial for prevention [3]. - The current situation of myopia among children and adolescents in China is serious, with a trend towards younger onset and higher degrees of myopia [3][4]. - Protecting the "hyperopia reserve" in children is essential, as many children deplete this reserve before age six, increasing their risk of developing myopia [4]. Group 2: Eye Health Initiatives - Aier Eye Hospital has advocated for annual eye health checks to promote early prevention, screening, diagnosis, and treatment of eye diseases [6]. - The organization has been actively involved in public education on eye health across various age groups [6]. Group 3: Myopia Surgery Trends - There has been a significant increase in the number of myopia surgeries in recent years, with the average age of patients in China being younger than in Europe [7]. - The main types of myopia surgery include laser corneal surgery and intraocular lens implantation, both of which have evolved over the past 30 years [9][10]. - Personalized and customized approaches to myopia surgery are becoming more prevalent, taking into account various eye parameters for optimal outcomes [11]. Group 4: Post-Surgery Care - Post-operative care and maintaining good eye habits are critical for the success of myopia surgery [13]. - Patients are advised to avoid eye rubbing and strenuous activities in the first week after surgery and to have regular follow-ups to monitor any complications [13].

Group 1 - The "Healthy Liaoning Colorful Vision 2025 National Eye Care Public Welfare Action" was launched in Shenyang, aiming to promote eye health awareness and establish a comprehensive eye health service ecosystem [2] - The initiative includes the release of the "2025 National Eye Care Lifestyle Guide," which provides localized eye care solutions for different demographic groups, including children, youth, middle-aged, elderly, and diabetic patients [2] - The "AI Smart Prevention and Treatment Month for Diabetic Eye Diseases" was also initiated, utilizing AI retinal cameras for eye health screenings across multiple locations in Liaoning province [2] Group 2 - The "Blue Ribbon Public Welfare Action for Exam Candidates" was launched to protect the eye health of students during the important exam season, with medical service stations set up at various exam sites in Liaoning [3] - The company aims to leverage this initiative to collaborate with authoritative media and community healthcare networks, promoting public awareness, scientific education, and AI-driven healthcare solutions [3] - The goal is to create a new ecosystem for smart eye health management, making communities the first line of defense for public health and utilizing technological innovations to benefit the public [3]

Group 1 - The "2025 National Visual Health Science Popularization Action" was officially launched on June 5, 2025, with the theme "Technology Empowers Eye Health, Building a Bright New Future Together" [1] - The initiative aims to explore the latest practical achievements of new information technology in the field of eye health and to break the public's cognitive blind spots regarding new applications and devices through expert science popularization [1] - The event coincides with the 30th National "Eye Care Day," highlighting the establishment of a near-sighted prevention work system led by the government and involving multiple departments, schools, parents, and students [2] Group 2 - The National Market Supervision Administration has been advancing near-sighted prevention work through policy implementation, strict regulation, and public education, with plans to continue addressing market issues to support youth eye health [4] - The National Health Commission has established a comprehensive monitoring network and improved standards and guidelines to protect children's and adolescents' vision health, focusing on early intervention and scientific research [6] - Experts emphasized the importance of artificial intelligence in eye health, particularly in prevention, diagnosis, treatment, and education, showcasing its potential to enhance medical innovation [10] Group 3 - The event featured discussions on various eye health topics, including modern artificial lenses and dry eye treatment, highlighting advancements in technology and treatment methods [17] - The "People's Health 'Into Campus' Care Plan" was officially launched during the event, aiming to integrate resources for science education in schools and enhance youth health literacy [19][21] - The initiative received professional guidance from several prestigious universities and hospitals, with support from various organizations in the eye care sector [20]

我国已于2014年消灭了致盲性沙眼，并于2020年末获得世界卫生组织的正式认证；近年儿童青少年眼健 康整体水平不断提升，2022年儿童青少年总体近视率(51.9%)比2018年(53.6%)下降1.7个百分点，目前0- 6岁儿童每年眼保健和视力检查覆盖率达到95.4%；有效屈光不正矫正覆盖率不断提高，高度近视导致 的视觉损伤人数逐步减少；全国百万人口白内障手术率(CSR)达到3500以上，提前完成了《"十四五"全 国眼健康规划》中CSR的有关目标；《中国卫生健康统计年鉴》显示，2023年我国眼科执业(助理)医师 已达到6.7万名，每十万人口拥有眼科医师数为4.7名，超过《"十四五"全国眼健康规划》中的有关目 标。 主场活动前后，全国和北京市防盲技术指导组组织委员单位以"线上+线下"的形式举办了一系列眼健康 论坛及科普活动并通过多个媒体推送，旨在提升公众对眼健康知识的知晓度。活动现场还设置了科普游 戏互动区，以及人工智能眼健康筛查、近视防控、干眼防治等设备展示与体验区。 此外，大型眼健康咨询义诊活动在北京同仁医院亦庄院区同步举行，来自眼底、青光眼、眼角膜、白内 障、医学视光等多个专业方向的医务人员，现场为市民群 ...

Group 1 - The core viewpoint of the news is that He Eye Hospital's stock has seen a recent increase, closing at 23.33 yuan with a 3.32% rise, while its market-to-book ratio has reached a new low in 112 days at 1.93, with a total market value of 3.687 billion yuan [1] - The company has experienced a net inflow of main funds amounting to 5.7969 million yuan on June 5, with a total inflow of 18.9978 million yuan over the past five days, indicating a positive trend in fund flow [1] - He Eye Hospital specializes in personalized and intelligent eye health management services, offering products such as refractive surgery, cataract treatment, vitreoretinal treatment, and other eye disease treatments [1] Group 2 - The latest financial report for the first quarter of 2025 shows that the company achieved an operating income of 291 million yuan, representing a year-on-year increase of 2.35%, and a net profit of 32.5319 million yuan, up 12.27% year-on-year, with a gross profit margin of 43.80% [1] - In comparison to industry averages, He Eye Hospital's price-to-earnings (PE) ratios are significantly lower, with a trailing PE of -154.63 and a static PE of -134.56, while the industry average PE is 40.82 [2] - The company's market value stands at 3.687 billion yuan, which is lower than the industry median of 5.893 billion yuan [2]

STAAR Surgical Company (STAA) FY Conference Summary Company Overview - STAAR Surgical is a 43-year-old company recognized as a global leader in ophthalmic surgery, offering a superior solution to LASIK with its EVO ICL lens technology [3][4] - The company operates in 75 countries, holding a significant refractive market share, particularly in Japan where it has a 70% share due to negative perceptions of LASIK [5][6] Core Points and Arguments - **Product Advantages**: The EVO ICL lens is reversible, provides UV protection, does not induce dry eye, and preserves corneal tissue, leading to rapid recovery and better contrast vision [4][12][14] - **Market Position**: STAAR holds approximately 12% of the global refractive market share, with significant opportunities for growth, especially in China and India [6][20] - **Growth Drivers**: The company anticipates growth driven by macroeconomic improvements and increased patient comfort with surgical options as word-of-mouth spreads [6][10][30] - **Financial Performance**: In FY 2024, STAAR reported revenues of $313.9 million, a 3% decline from FY 2023, primarily due to challenges in the Chinese market [10][34] - **Margins**: Gross margins decreased from 78.5% to 65.8% due to reduced production volume and increased reserves for obsolete inventory [35] Challenges and Strategic Focus - **Market Challenges**: The company faces headwinds from patient reluctance to pursue surgical options, particularly in the U.S., where fear of surgery is a significant barrier [6][27] - **China Market Concerns**: There are investor concerns regarding inventory levels and tariff issues in China, but the company believes these are transitory and manageable [21][41] - **Operational Restructuring**: STAAR is undergoing a restructuring to reduce SG&A expenses to a $225 million run rate, which is expected to improve financial health [36][42] Future Outlook - **Market Potential**: The myopia epidemic is expected to grow, with projections indicating that 50% of the global population may be affected by 2050, presenting a substantial market opportunity for STAAR [45] - **Long-term Confidence**: The company is optimistic about returning to historical earnings and cash flow generation as macroeconomic conditions improve [46][51] - **Strategic Shift**: There is a focus on expanding the market beyond current surgical candidates to include those using glasses and contacts, aiming to increase overall market penetration [55] Additional Insights - **Regulatory Wins**: Recent approvals in China for new product variations are seen as positive developments that could enhance market presence [17][22] - **Sales Growth**: Despite challenges, the company achieved a 9% year-over-year growth in markets outside of China, indicating resilience and potential for recovery [38] This summary encapsulates the key points discussed during the STAAR Surgical conference, highlighting the company's strengths, challenges, and strategic direction moving forward.